Matthew Hamilton Rosenberg’s Core Laboratories CLB Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-402	Closed	-$6.89K	–	816
2024 Q1	$6.89K	Hold	402	–	–	﹤0.01%	660
2023 Q4	$7.1K	Buy	402 +194	+93%	+$3.91K	﹤0.01%	660
2023 Q3	$4.99K	Hold	208	–	–	﹤0.01%	685
2023 Q2	$4.84K	Hold	208	–	–	﹤0.01%	690
2023 Q1	$4.59K	Hold	208	–	–	﹤0.01%	733
2022 Q4	$4.22K	Hold	208	–	–	﹤0.01%	731
2022 Q3	$3K	Hold	208	–	–	﹤0.01%	747
2022 Q2	$4K	Hold	208	–	–	﹤0.01%	705
2022 Q1	$7K	Hold	208	–	–	﹤0.01%	649
2021 Q4	$5K	Hold	208	–	–	﹤0.01%	644
2021 Q3	$6K	Hold	208	–	–	﹤0.01%	617
2021 Q2	$8K	Hold	208	–	–	﹤0.01%	527
2021 Q1	$6K	Hold	208	–	–	﹤0.01%	515
2020 Q4	$6K	Hold	208	–	–	﹤0.01%	500
2020 Q3	$3K	Hold	208	–	–	﹤0.01%	507
2020 Q2	$4K	Buy	+208	New	+$3.73K	﹤0.01%	522

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Matthew Hamilton Rosenberg's CLB Position: Q2 2024 in Review

Matthew Hamilton Rosenberg sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 402 shares — an estimated $6.89K sold.

Matthew Hamilton Rosenberg first reported a position in CLB in Q2 2020 and held it in 16 quarters. The position peaked at $8K in Q2 2021. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

Matthew Hamilton Rosenberg reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 402 Core Laboratories shares in Q2 2024, an estimated $6.89K.
Matthew Hamilton Rosenberg first reported a position in Core Laboratories in Q2 2020 and held it in 16 quarters.
Matthew Hamilton Rosenberg's Core Laboratories position peaked at $8K in Q2 2021.
194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2024, filed 26 Jul 2024.